229 related articles for article (PubMed ID: 23706402)
1. Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability.
Harvey BS; Nicotra LL; Vu M; Smid SD
Cytokine; 2013 Aug; 63(2):209-17. PubMed ID: 23706402
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model.
Harvey BS; Sia TC; Wattchow DA; Smid SD
Cytokine; 2014 Feb; 65(2):236-44. PubMed ID: 24238999
[TBL] [Abstract][Full Text] [Related]
3. Δ
Shang VC; Kendall DA; Roberts RE
Biochem Pharmacol; 2016 Nov; 120():63-71. PubMed ID: 27641813
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin ethanolamides attenuate damage in a human explant colitis model.
Nicotra LL; Vu M; Harvey BS; Smid SD
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():22-9. PubMed ID: 23380599
[TBL] [Abstract][Full Text] [Related]
5. Effects of pro-inflammatory cytokines, lipopolysaccharide and COX-2 mediators on human colonic neuromuscular function and epithelial permeability.
Safdari BK; Sia TC; Wattchow DA; Smid SD
Cytokine; 2016 Jul; 83():231-238. PubMed ID: 27177092
[TBL] [Abstract][Full Text] [Related]
6. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease.
Tartakover Matalon S; Ringel Y; Konikoff F; Drucker L; Pery S; Naftali T
United European Gastroenterol J; 2020 Apr; 8(3):271-283. PubMed ID: 32213014
[TBL] [Abstract][Full Text] [Related]
8. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.
Wright K; Rooney N; Feeney M; Tate J; Robertson D; Welham M; Ward S
Gastroenterology; 2005 Aug; 129(2):437-53. PubMed ID: 16083701
[TBL] [Abstract][Full Text] [Related]
10. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium.
Kimball ES; Schneider CR; Wallace NH; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G364-71. PubMed ID: 16574988
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors.
Su TF; Zhao YQ; Zhang LH; Peng M; Wu CH; Pei L; Tian B; Zhang J; Shi J; Pan HL; Li M
Eur J Pain; 2012 May; 16(5):624-35. PubMed ID: 22337285
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
15. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Matos I; Bento AF; Marcon R; Claudino RF; Calixto JB
Mol Immunol; 2013 Jul; 54(3-4):482-92. PubMed ID: 23454360
[TBL] [Abstract][Full Text] [Related]
16. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder.
Christie S; Zagorodnyuk V
Am J Physiol Renal Physiol; 2021 May; 320(5):F859-F865. PubMed ID: 33749323
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
Singh UP; Singh NP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 2012 Jan; 258(2):256-67. PubMed ID: 22119709
[TBL] [Abstract][Full Text] [Related]
18. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
[TBL] [Abstract][Full Text] [Related]
19. Functional CB2 type cannabinoid receptors at CNS synapses.
Morgan NH; Stanford IM; Woodhall GL
Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.
Abidi AH; Presley CS; Dabbous M; Tipton DA; Mustafa SM; Moore BM
Arch Oral Biol; 2018 Mar; 87():79-85. PubMed ID: 29274621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
